Functional Outcome and Survival rate of Metastatic Bone Disease on femur And Pelvic Bone after Surgical Treatmentdoi:10.31838/hiv22.02.684Husna Dharma PuteraAhmad Fauzi KamalYogi PrabowoHIV Nursing
In the past, the life expectancy of men with metastaticprostate cancerwas 2-3 years. Butwith advancements in medicine and care, the life expectancy of men with metastatic prostatecancerhas increased to about 5-6 years. The 5-year survival rate of metastatic prostate canceris 28%, which is m...
Nevertheless, specific subgroups of metastatic breast cancer patients exist, for which depending on the treatment given, the prognosis is improved so that some patients can survive for some time, particularly for those with limited organs involvement such as involvement with bone and/or skin only. ...
To minimize complications, patients must be carefully selected based on expected length of survival, the use of radiation therapy, presence of neurologic deficit, and impending spinal instability or collapse caused by bone destruction. 展开 关键词: metastatic disease spinal metastases spine tumor ...
The median survival of women with metastatic breast cancer (MBC) is 18-24 months, and fewer than 5% are alive and disease free at 5 years. We report toxici... M Martino,A Ballestrero,A Zambelli,... - 《Bone Marrow Transplant》 被引量: 92发表: 0年 Long-term survival of patients ...
Our model allows us to quantify the dissemination rate between tumor, bone, lungs liver and brain connected by a seeding network displayed in Fig. 1. The routes of metastasis formation for breast cancer have been debated and are not yet established10. The anatomical motivation behind our seeding...
factors (age, performance status, number of involved vertebrae, ambulatory status, other bone metastases, visceral metastases, interval from cancer diagnosis to radiotherapy of MSCC, time developing motor deficits) plus the fractionation regimen were retrospectively investigated for associations with survival...
et al. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. Neoplasia 12, 116–127 (2010). CAS PubMed PubMed Central Google Scholar Kobayashi, A. et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like ...
Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer. Urol Oncol. 2014;32(6):761-768. doi:10.1016/j.urolonc.2014.03.024 PubMedGoogle ScholarCrossref Error in Byline JAMA Network Open Correction ...
Importantly, prostate cancer bone metastases were suppressed by oral celecoxib (15 ppm, equivalent to the standard human dose of 100 mg capsules). For colorectal cancer, indomethacin (50 mg × 2 daily) or celecoxib (100 mg × 2 daily) treatment for three days before surgery promoted ...